HK1207293A1 - Composition for the treatment of inflammatory and immune disorders - Google Patents

Composition for the treatment of inflammatory and immune disorders

Info

Publication number
HK1207293A1
HK1207293A1 HK15107890.9A HK15107890A HK1207293A1 HK 1207293 A1 HK1207293 A1 HK 1207293A1 HK 15107890 A HK15107890 A HK 15107890A HK 1207293 A1 HK1207293 A1 HK 1207293A1
Authority
HK
Hong Kong
Prior art keywords
inflammatory
treatment
composition
immune disorders
immune
Prior art date
Application number
HK15107890.9A
Other languages
English (en)
Chinese (zh)
Inventor
Paul Frederick Turner
Original Assignee
Eaglepharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012901301A external-priority patent/AU2012901301A0/en
Application filed by Eaglepharma Pty Ltd filed Critical Eaglepharma Pty Ltd
Publication of HK1207293A1 publication Critical patent/HK1207293A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK15107890.9A 2012-04-02 2015-08-14 Composition for the treatment of inflammatory and immune disorders HK1207293A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2012901301A AU2012901301A0 (en) 2012-04-02 Treatment of inflammatory and immune disorders
PCT/GB2013/050865 WO2013150292A1 (en) 2012-04-02 2013-04-02 Composition for the treatment of inflammatory and immune disorders

Publications (1)

Publication Number Publication Date
HK1207293A1 true HK1207293A1 (en) 2016-01-29

Family

ID=48184233

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107890.9A HK1207293A1 (en) 2012-04-02 2015-08-14 Composition for the treatment of inflammatory and immune disorders

Country Status (9)

Country Link
US (1) US9387218B2 (xx)
EP (1) EP2836208B1 (xx)
JP (1) JP6188784B2 (xx)
CN (1) CN104427982B (xx)
AU (1) AU2013203825B2 (xx)
CA (1) CA2869243C (xx)
HK (1) HK1207293A1 (xx)
MX (1) MX355103B (xx)
WO (1) WO2013150292A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018051154A1 (en) * 2016-09-15 2018-03-22 Perscellmed Roth & Partner Compound of zinc salicylate and sulphur combination as a novel treatment for asthma and copd

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US20030069202A1 (en) * 2000-06-02 2003-04-10 Kern Kenneth Norman Compositions, kits, and methods for promoting defined health benefits
US6902739B2 (en) * 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
US6841173B2 (en) * 2002-03-26 2005-01-11 Peter L. Reynolds Compositions and methods directed towards sore muscles and joints
US20060251750A1 (en) * 2002-09-30 2006-11-09 Tabor Aaron T Soy formulations and their use in skin care
JP2005013124A (ja) * 2003-06-27 2005-01-20 Toyo Shinyaku:Kk 美容効果を有する食品組成物
US20060029647A1 (en) * 2004-02-09 2006-02-09 Friesen Kim G Composition and method for use in cartilage affecting conditions
US20050176807A1 (en) * 2004-02-09 2005-08-11 Friesen Kim G. Composition and method for use in cartilage affecting conditions
US20070020218A1 (en) 2005-07-21 2007-01-25 Eileen Richardson Composition and method for the treatment of psoriasis
US7335384B2 (en) 2006-03-17 2008-02-26 4K Nutripharma International Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
CA2816595C (en) * 2010-10-07 2018-11-27 Eaglepharma Pty Ltd Combination therapy for the treatment of depression and other non-infectious diseases

Also Published As

Publication number Publication date
EP2836208B1 (en) 2019-09-25
JP2015512439A (ja) 2015-04-27
US20150111850A1 (en) 2015-04-23
WO2013150292A1 (en) 2013-10-10
MX2014011922A (es) 2015-12-03
US9387218B2 (en) 2016-07-12
EP2836208A1 (en) 2015-02-18
CN104427982A (zh) 2015-03-18
CA2869243C (en) 2021-03-16
CA2869243A1 (en) 2013-10-10
AU2013203825B2 (en) 2015-12-17
MX355103B (es) 2018-04-05
AU2013203825A1 (en) 2013-10-17
CN104427982B (zh) 2017-05-17
JP6188784B2 (ja) 2017-08-30

Similar Documents

Publication Publication Date Title
HK1249507A1 (zh) 用於治療炎性障礙的新化合物及其藥物組合物
IL257581A (en) New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
IL239355A0 (en) Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders
EP2847152A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF METABOLIC SYNDROME
IL225239A0 (en) Compounds for the treatment of acne and related diseases
ZA201408055B (en) Compositions and methods for the treatment of local pain
ZA201408060B (en) Compositions and methods for the treatment of neurological disorders
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
ZA201408061B (en) Compositions and methods for the treatment of neurological disorders
IL234616A0 (en) A herbal preparation for the treatment of metabolic diseases
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome
HK1207293A1 (en) Composition for the treatment of inflammatory and immune disorders
ZA201408045B (en) Compositions and methods for the treatment of inflammation and lipid disorders
AU2012901301A0 (en) Treatment of inflammatory and immune disorders
GB201201779D0 (en) Treatment of inflammatory disorders